---
figid: PMC10383978__metabolites-13-00774-g003
figtitle: Differential Inhibition of Anaplerotic Pyruvate Carboxylation and Glutaminolysis-Fueled
  Anabolism Underlies Distinct Toxicity of Selenium Agents in Human Lung Cancer
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC10383978
filename: metabolites-13-00774-g003.jpg
figlink: /pmc/articles/PMC10383978/figure/metabolites-13-00774-f003/
number: F3
caption: 'Distinct capacity of MSeA, selenite, and SeM in blocking glutaminolysis
  in A549 and H1299 cells. A549 or H1299 cells were treated with 5 µM MSeA, 6.25 µM
  selenite, or 500 µM SeM for 24 h with 13C5,15N2-Gln (n = 2) as tracer, as described
  in Methods. Polar metabolites were analyzed by GC-MS (A–G). Pathways shown track
  12C (●), 14N (◆), 13C from glutaminolysis + PDH-initiated Krebs cycle (●), 13C from
  glutaminolysis + Krebs cycle + ME (●)/ME + PC (●) or glutaminolysis + reductive
  carboxylation (RedC, ●), and 15N (◆) from glutaminolysis/transamination; not all
  expected 13C and/or 15N labeled products are shown. The color bars (■, ■, ■, ■)
  denote the 13C isotopologues related to the labeled products in the pathway scheme.
  m1-6: 13C1-6 isotopologues; GLS: glutaminase; IDH: isocitrate dehydrogenase; ME:
  malic enzyme; ACL: ATP-citrate lyase; LDH, PDH, PC, AST: abbreviations as in  and
  . See  for statistical analysis.'
papertitle: Differential Inhibition of Anaplerotic Pyruvate Carboxylation and Glutaminolysis-Fueled
  Anabolism Underlies Distinct Toxicity of Selenium Agents in Human Lung Cancer.
reftext: Teresa W.-M. Fan, et al. Metabolites. 2023 Jul;13(7):774.
year: '2023'
doi: 10.3390/metabo13070774
journal_title: Metabolites
journal_nlm_ta: Metabolites
publisher_name: MDPI
keywords: non-small cell lung cancer | selenite | methylseleninic acid | selenomethionine
  | pyruvate carboxylation | glutaminolysis | chemoprevention | stable isotope resolved
  metabolomics
automl_pathway: 0.500411
figid_alias: PMC10383978__F3
figtype: Figure
redirect_from: /figures/PMC10383978__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10383978__metabolites-13-00774-g003.html
  '@type': Dataset
  description: 'Distinct capacity of MSeA, selenite, and SeM in blocking glutaminolysis
    in A549 and H1299 cells. A549 or H1299 cells were treated with 5 µM MSeA, 6.25
    µM selenite, or 500 µM SeM for 24 h with 13C5,15N2-Gln (n = 2) as tracer, as described
    in Methods. Polar metabolites were analyzed by GC-MS (A–G). Pathways shown track
    12C (●), 14N (◆), 13C from glutaminolysis + PDH-initiated Krebs cycle (●), 13C
    from glutaminolysis + Krebs cycle + ME (●)/ME + PC (●) or glutaminolysis + reductive
    carboxylation (RedC, ●), and 15N (◆) from glutaminolysis/transamination; not all
    expected 13C and/or 15N labeled products are shown. The color bars (■, ■, ■, ■)
    denote the 13C isotopologues related to the labeled products in the pathway scheme.
    m1-6: 13C1-6 isotopologues; GLS: glutaminase; IDH: isocitrate dehydrogenase; ME:
    malic enzyme; ACL: ATP-citrate lyase; LDH, PDH, PC, AST: abbreviations as in  and
    . See  for statistical analysis.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - cn
  - Pp1-13C
  - l(1)17Cb
  - ca
  - sm
  - ast
  - Semp1
  - AstA
  - som
  - se
  - rl
  - Men
  - Ldh
  - Pc
  - ATPCL
  - CycE
  - cyc
  - lncRNA:iab8
  - cu
  - Coa
  - La
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - GOT1
  - SLC17A5
  - TGM1
  - GRHL3
  - SLAMF6
  - ME1
  - PCDHB16
  - LDHA
  - LDHB
  - LDHC
  - PC
  - ACLY
  - ME2
  - CELSR1
  - PCDHB11
  - TPO
  - Glucose
  - Pyruvate
  - Asp
  - CH MSASO SOM CH
  - CH
  - Lactate
  - Citrate
  - CO2 Pyruvate
  - Succinate
  - Isocitrate
  - Succinyl
  - 15NH4
  - Glu
---
